Why tumor typing is important, David Botstein
Interviewee: David Botstein. David Botstein talks about how tumor typing using genome-wide analysis will help doctors determine the most appropriate treatments for their patients. (DNAi Location: Applications > Genes and medicine > Genetic profiling > David Botstein > Why tumor typing is important)
And the reason that's important for patients is that treatments that work for one kind of tumor may not work for another kind of tumor, even though they look the same to the pathologist. And under the circumstances where we can separate the apples from the oranges, we can actually apply the cure for the orange disease to the oranges, and not have it confused by the response of the apples which may be no response or even a bad response. In leukemia, especially childhood leukemia, this has been very successful with even very standard treatments, so that we believe is going to be an immediate benefit to the patients.
david botstein,childhood leukemia,genetic profiling,location applications,dnai,interviewee,pathologist,leukemia,oranges,apples,genes,dna,doctors,circumstances,cancer,benefit,medicine
David Botstein discusses how identifying the molecular mechanisms of cancer will lead to the development of improved therapies.
David Botstein talks about the goal of using microarray analysis to improve cancer diagnosis.
David Botstein (sitting with Pat Brown) talks about how innovations in genomics might lead to personalized medicine.
Brian Druker reflects on the importance of understanding the causes of cancer for developing new treatments.
Brian Druker talks about the drug he developed as a turning point in the war on cancer.
Bud recounts receiving the diagnosis that he had chronic myeloid leukemia.
Brian Druker talks about how the drug he designed targets the molecular cause of CML.
Stephen Fodor talks about how an individual's gene expression profile can help determine what therapies might work best.
Pat Brown talks about using microarrays to discover the differences between cancer cells and healthy cells.
15525. How Gleevec works to alleviate symptoms of myeloid leukemia, 3D animation with basic narration
View the animation to find out how the drug Gleevecâ¢ inhibits the molecular cause of chronic myeloid leukemia.